Expertise
Lifescience is a vast field, due to that one must focus on a limited number of subjects to be acknowledged as a true expert. I was already fascinated by minimally invasive technical devices for disease treatment at a very early stage in my career. Up to today I spend more than a decade in the field of capsule endoscopy. According to my experience it is not enough to just release a product, as soon as a technonology is ready to launch. The true issue is about closing the gap in between early adaptors and the early majority.
It is important to offer early stage marketing material to embed innovations in daily routine. Guidelines, detailed patients profiles and pathways as well as a dedicated role management are essential for the breakthrough of any innovation.
Medical Affairs will support you!
- To develop and execute your clinical marketing strategy and programs for EMEA.
- To outline opportunities to expand clinical application of your product.
- To develop relationships with customers and KOL and provide ongoing clinical support to drive adoption if you whish.
- Advice your company to comply to GDPR and MDR (Post Market Surveillance)
Optionally I create and deliver clinical product-related presentations, seminars and educational programs, provide clinical and customer input to internal teams as it related to the use of products and positioning with key customer groups.
Publications
- Baltes P, Bota M, Albert J, Philipper M, Hörster H-G, Hagenmüller F, Steinbrück I, Jakobs R, Bechtler M, Hartmann D, Neuhaus H, Charton J-P, Mayershofer R, Hohn H, Rösch T, Groth S, Nowak T, Wohlmuth P, Keuchel M (2018): PillCamColon2 after incomplete colonoscopy – A prospective multicenter study. World J Gastroenterol. 2018 Aug 21; 24(31): 3556–3566.
- Nowak T (2017): Global perspective on capsule endoscopy. Ann Transl Med. Nov;5(21):422.
- Schäfer S, Vogt T, Nowak T, Kann PH (2008): Pituitary function and the somatotrophic system in patients with idiopathic Parkinson’s disease under chronic dopaminergic therapy. J Neuroendocrinol. 2008 Jan;20(1):104-9.
- Herrmann BL, Berg C, Vogel E, Nowak T, Renzing-Koehler K, Mann K, Saller B. (2004): Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome. Horm Metab Res. 2004 Jan;36(1):54-61.
- Donaubauer J, Kiess W, Kratzsch J, Nowak T, Steinkamp H, Willgerodt H, Keller E and Study Group (2003): Re-assessment of growth hormone secretion in young adult patients with childhood-onset growth hormone deficiency. Clinical Endocrinology 58 (4): 456-463
- Nowak T, Nishida K, Shimoda S, Konno Y, Ichinose K, Sakakida M, Shichiri M, Nakabayashi N, Ishihara K (2000): Biocompatibility of MPC: in vivo evaluation for clinical application. J Artif Organs 3: 39-46
- Nowak T (1997): Dive under in Japan. SDSK Newsletter 30
- Shimoda S, Nishida K, Sakakida M, Konno Y, Ichinose K, Uehara M, Nowak T, Shichiri M. (1997): Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas. Front Med Biol Eng. 8(3):197-211.
- Nowak T (1996): Meistersinger, Biologie der Buckelwale. Unterwasser, das Tauchmagazin. Ausgabe 6/1996: 138-143
- Nowak T, Preidel W, Ruprecht L, Stanzel MJ (1994): Die Biokompatibilität des elektrokatalytischen Glucosesensors: Langzeitimplantationen in Minipigs, Biomedical Engineering, Band 39, Heft s1
- Nowak T, Preidel W, Ruprecht L, Stanzel MJ (1994): Biocompatibility of the intravasal implantable glucose sensor. Horm metab Res 27: 74-75 (A54)
- Lager W, von Lucadou I, Nischik H, Nowak T, Preidel W, Ruprecht L, Stanzel MJ, Tegeder V (1994): Implantable electrocatalytic glucose sensor. Horm metab Res 26(11): 526-530
- Lager W, von Lucadou I, Nischik H, Nowak T, Preidel W, Ruprecht L, Stanzel MJ, Tegeder V (1994): Electrocatalytic glucose sensor for long-term use. Int J Artif Organs.17(3):183-8.
